Alphina Therapeutics, Inc. — Form D
Alphina Therapeutics, Inc. of New Haven, CT, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-15. The offering totals $40.0M, of which $16.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-15
- Form: D
- Accession: 0001882991-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $16.9M
- Remaining: $23.1M
- Investors: 19
- Date of first sale: 2021-09-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413373
Issuer
- Name: Alphina Therapeutics, Inc.
- CIK: 0001882991
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 Church Street, New Haven, CT, 06510
- Phone: (650) 438-8738
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Anurag L Agarwal | Director | Wynnewood, PA |
| Ranjit L Bindra | Director | New Haven, CT |
| Colleen L Cuffaro | Director | Westport, CT |
| Kevin L Rakin | Director | Westport, CT |
| Ranjit L Bindra | Executive Officer | New Haven, CT |
| Stanley L Choy | Executive Officer | Greenwich, CT |
| Colleen L Cuffaro | Executive Officer | Westport, CT |
| Kevin L Rakin | Executive Officer | Westport, CT |
| Barbara J Fox | Director | New Haven, CT |
| Barbara J Fox | Executive Officer | New Haven, CT |
| Colleen J Cuffaro | Director | Westport, CT |
| Nicholas J Galli | Director | New Haven, CT |
| Nicholas J Galli | Executive Officer | New Haven, CT |
| Kevin J Rakin | Director | New Haven, CT |
| Matthew J Cohen | Director | Bala Cynwyd, PA |
| Ranjit J Bindra | Director | New Haven, CT |
Other filings by this issuer (1)
More